EP1233671A4 - Compositions and methods for drug delivery using amphiphile binding molecules - Google Patents
Compositions and methods for drug delivery using amphiphile binding moleculesInfo
- Publication number
- EP1233671A4 EP1233671A4 EP00982310A EP00982310A EP1233671A4 EP 1233671 A4 EP1233671 A4 EP 1233671A4 EP 00982310 A EP00982310 A EP 00982310A EP 00982310 A EP00982310 A EP 00982310A EP 1233671 A4 EP1233671 A4 EP 1233671A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- methods
- drug delivery
- binding molecules
- amphiphile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16783699P | 1999-11-29 | 1999-11-29 | |
US167836P | 1999-11-29 | ||
PCT/US2000/032612 WO2001037665A1 (en) | 1999-11-29 | 2000-11-29 | Compositions and methods for drug delivery using amphiphile binding molecules |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1233671A1 EP1233671A1 (en) | 2002-08-28 |
EP1233671A4 true EP1233671A4 (en) | 2005-11-02 |
Family
ID=22609038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00982310A Withdrawn EP1233671A4 (en) | 1999-11-29 | 2000-11-29 | Compositions and methods for drug delivery using amphiphile binding molecules |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1233671A4 (en) |
WO (1) | WO2001037665A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6509323B1 (en) | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
US7091192B1 (en) | 1998-07-01 | 2006-08-15 | California Institute Of Technology | Linear cyclodextrin copolymers |
US7375096B1 (en) | 1998-12-04 | 2008-05-20 | California Institute Of Technology | Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network |
TWI321054B (en) | 2000-12-19 | 2010-03-01 | California Inst Of Techn | Compositions containing inclusion complexes |
IL161733A0 (en) * | 2001-11-02 | 2005-11-20 | Insert Therapeutics Inc | Methods and compositions for therapeutic use of rna interference |
US20030224055A1 (en) * | 2002-05-28 | 2003-12-04 | Lewis David L. | Compositions and processes for inhibiting gene expression using polynucleotides |
FR2842106B1 (en) * | 2002-07-11 | 2006-07-14 | Centre Nat Rech Scient | AQUEOUS DISPERSIONS OF NANOMETRIC OR MICROMETRIC PARTICLES FOR THE ENCAPSULATION OF CHEMICAL COMPOUNDS |
KR20120104412A (en) | 2002-09-06 | 2012-09-20 | 인설트 테라페틱스, 인코퍼레이티드 | Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
EP1549269A4 (en) | 2002-10-09 | 2010-10-06 | Cerulean Pharma Inc | Cyclodextrin-based materials, compositions and uses related thereto |
JP2010516625A (en) | 2007-01-24 | 2010-05-20 | インサート セラピューティクス, インコーポレイテッド | Polymer-drug conjugates with tether groups for controlled drug delivery |
EP2438908A1 (en) | 2010-10-11 | 2012-04-11 | Vectum Pharma, S.L. | Anchoring compositions for topical applications |
WO2014055493A1 (en) | 2012-10-02 | 2014-04-10 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000001418A1 (en) * | 1998-07-02 | 2000-01-13 | Genzyme Corporation | Transgene expression in polarized cells |
WO2001015755A2 (en) * | 1999-09-01 | 2001-03-08 | Genecure Pte Ltd | Methods and compositions for delivery of pharmaceutical agents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5283185A (en) * | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
US5650096A (en) * | 1994-12-09 | 1997-07-22 | Genzyme Corporation | Cationic amphiphiles for intracellular delivery of therapeutic molecules |
US5965434A (en) * | 1994-12-29 | 1999-10-12 | Wolff; Jon A. | Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds |
US5942634A (en) * | 1997-05-09 | 1999-08-24 | Genzyme Corporation | Cationic amphiphiles for cell transfections |
-
2000
- 2000-11-29 WO PCT/US2000/032612 patent/WO2001037665A1/en active Search and Examination
- 2000-11-29 EP EP00982310A patent/EP1233671A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000001418A1 (en) * | 1998-07-02 | 2000-01-13 | Genzyme Corporation | Transgene expression in polarized cells |
WO2001015755A2 (en) * | 1999-09-01 | 2001-03-08 | Genecure Pte Ltd | Methods and compositions for delivery of pharmaceutical agents |
Non-Patent Citations (4)
Title |
---|
CROYLE MA ET AL: "Beta cyclodextrins enhance gene delivery to the intestine", PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE BIOACTIVE MATERIALS, vol. 24, 1997, pages 675 - 676, XP002122911, ISSN: 1022-0178 * |
FREEMAN D J ET AL: "THE INFLUENCE OF SODIUM GLYCOCHOLATE AND OTHER ADDITIVES ON THE IN VIVO TRANSFECTION OF PLASMID DNA IN THE LUNGS", PHARMACOLOGICAL RESEARCH, ACADEMIC PRESS, LONDON, GB, vol. 13, no. 2, 1 February 1996 (1996-02-01), pages 202 - 209, XP000646438, ISSN: 1043-6618 * |
HABUS I ET AL: "SYNTHESIS, HYBRIDIZATION PROPERTIES, NUCLEASE STABILITY, AND ADAMANTANE CONJUGATES. CELLULAR UPTAKE OF THE OLIGONUCLEOTIDE-AMINO- CYCLODEXTRINS AND", BIOCONJUGATE CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, vol. 6, no. 4, 1 July 1995 (1995-07-01), pages 327 - 331, XP000517222, ISSN: 1043-1802 * |
See also references of WO0137665A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1233671A1 (en) | 2002-08-28 |
WO2001037665A1 (en) | 2001-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI367096B (en) | Vitamin-receptor binding drug delivery conjugates and pharmaceutical compositions | |
AU3692001A (en) | Compositions and methods for enhancing drug delivery across biological membranesand tissues | |
AU2001235009A1 (en) | Drug delivery apparatus | |
IL138990A0 (en) | Matrices for drug delivery and methods for making and using the same | |
HUP0203588A3 (en) | Analgesic pharmaceutical compositions and their use | |
EP1367995A4 (en) | Compositions and methods for enhancing drug delivery across and into epithelial tissues | |
HK1049438B (en) | Sub-tenon drug delivery | |
HK1039571A1 (en) | Compositions and methods for mucosal delivery | |
AU2001232049A1 (en) | Improvements in and relating to controlling drug delivery apparatus | |
PL351387A1 (en) | Pharmaceutical composition | |
HUP0204372A3 (en) | Pharmaceutical compositions providing enhanced drug concentrations | |
EP1239831A4 (en) | Improved pharmaceutical compositions for poorly soluble drugs | |
AU5326100A (en) | Pharmaceutical compositions and methods for use | |
GB2355252B (en) | Improvements in drug delivery devices | |
IL151910A0 (en) | Compositions for drug delivery | |
HUP0302130A3 (en) | Combination pharmaceutical compositions and process for their preparation | |
EP1233671A4 (en) | Compositions and methods for drug delivery using amphiphile binding molecules | |
EP1165597A4 (en) | Bifunctional molecules for delivery of therapeutics | |
IL137559A0 (en) | Transdermal drug delivery system | |
HUP0200468A3 (en) | Resorcinol derivatives and pharmaceutical compositions containing them | |
IL153487A0 (en) | Pharmaceutical compositions and methods for use | |
EP1173192A4 (en) | Methods and compositions for targeted drug delivery | |
AU3926000A (en) | Methods and compositions for drug delivery | |
IL153897A0 (en) | Pharmaceutical compositions and methods for use | |
AU2002308649A1 (en) | Compositions and methods for enhancing drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020612 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050919 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 48/00 A Ipc: 7C 12N 15/88 B |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20051202 |